About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 2NCT02022072

Evaluation of Vital Capacity

Respiratory failure is the most common cause of death in neuromuscular diseases. The aim of this research is to evaluate the thoracopulmonary recruitment by comparison of inspiratory vital capacity (V...

Lead sponsor: Centre d'Investigation Clinique et Technologique 805•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre d'Investigation Clinique et Technologique 805

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•consent form signature
•Men and women aged over or equal to 18 years old
•Medical examination before the research
•Negative results of tests of pregnancy for the women at age to procreate or taking an effective contraceptive
•Patients with neuromuscular pathologies without tracheostmy - Vital Capacity \< 80% of theoretical value

Exclusion Criteria

•Refuse to participate at the research
•Patient under guardianship or under trusteeship
•pregnant Women
•Patients unable to cooperate
•Patients without a security social scheme (as beneficiary or bearer of rights)
•Usual contra-indications for an insufflation (haemoptise, recent pneumothorax, pulmonary emphysema, pleuresy, nausea, chronic obstructive pulmonary diseasee or asthma, recent lobectomy, intracranial hypertension, troubles of consciousness, unable to talk)

Related studies

RECRUITINGPhase 3

A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more

Measuring Physical Activity With ActivPal

NCT06084026 · Neuromuscular Diseases

A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J

NCT06151600 · Peripheral Neuropathy, Neuro-Degenerative Disease, and more

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

NCT07357428 · Amyotrophic Lateral Sclerosis, Neuromuscular Disease, and more

EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health

NCT07021638 · Home-based Programs, EzyGain, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 28, 2015Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment66

Start dateMay 2013

Last updatedJul 28, 2015

Condition

Respiration Disorders Neuromuscular Disease

Locations shown

Hôpital R Poincare

Garches

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 28, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions